« Previous Post | Next Post »

2025 Sedation Update – Virtual CE

Posted on April 20, 2025 in Continuing Education

 

Sedation 2025 update:  Different Regimens for A Different ERA

Navigating Medication Shortages

 

Saturday, May 31, 2025

9:00 am – 11:15 am (Central Time) Via Zoom

2 CE credits awarded only to those attending live

REGISTRATION IS CLOSED

Registration closes Wednesday, May 28th.

Cancellation/Refund Policy: Cancellations must be received in writing no later than Wednesday, May 28, 2025. A full refund, less a $10 processing fee, will be issued for those received by that deadline. All refunds will be processed within 30 days after the meeting. Questions? Monica Todd, texasacademypd@gmail.com  

Bobby Thikkurissy is Professor and Robert Creedon Chief of Dentistry, Cincinnati Children’s Hospital.

He obtained his DDS from New York University, an AEGD certificate from Wright Patterson AFB, and his certificate/Masters from The Ohio State University, additionally serving 8 years in the United States Air Force. Bobby became a Diplomate of the ABPD and entered full-time academics in 2006. He has served as Directors of a predoctoral program, in-patient service and a residency programs.

He has taught in the AAPD Sedation course since 2011 and has Chaired the AAPD Sedation committee as well as served on the ADA Council of Dental Education. His research and publications have focused on; procedural sedation, children with special needs, and morbidity of pain in children.  

Sedation 2025 update:  Different Regimens for A Different ERA

 

Course Description

Changes in medication availability, state dental practice acts/legislation and access to operating room services have all impacted the use of procedural sedation for the pediatric dental patient. This seminar will review how systemic process changes have influenced patient allocation and  regimens used for sedation. This seminar will cover newer (and older)  classes of agents, their pharmacokinetics/pharmacodynamics as well as the risks and benefits of sedative polypharmacy. Strategies on maintaining a high margin of safety in sedation will be an underlying focus and office strategies for safe sedation will be underscored.

Course Objectives

Attendees will be able to:

1. Understand Practical dosage considerations in the context of the Demerol shortage.
2. Understand pharmacokinetics of Morphine, Dexmedetomidine and Ketamine
3. Review the role of Nitrous oxide in these regimens
4. Be able to understand and implement key safety considerations for in-office procedural sedation

Schedule

9:00 – 11:00  Sedation 2025 Update 11:00 – 11:15  Q&A

Dr. Thikkurissy has no conflict of interest to declare. 

---